Given that circulating ICs increase the IL-10 synthesis and that IL-10 can, in turn, facilitate the production of autoantibodies, IL-10 may act pathogenically in SLE by amplifying and perpetuating an inflammatory cycle. Here, IL10 is linked to systemic lupus erythematosus.